You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Merck KGaA’s arpraziquantel validated by European Medicines Agency

Merck KGaA (Merck) – known as EMD Serono in the US and Canada – and the Pediatric Praziquantel Consortium have announced that the European Medicines Agency (EMA) has validated arpraziquantel with a view to receiving a positive opinion.